Abstract
Most patients with hypertrophic cardiomyopathy (HCM) usually complain of a reduced exercise capacity, and several factors have been advocated as possible causes of this clinical feature. The present single-center study was designed to investigate exercise capacity and its main clinical determinants in HCM patients. One hundred ninety seven patients of 223 evaluated underwent a complete clinical assessment, including Doppler echocardiography, cardiopulmonary exercise test (CPET) and, in most cases, cardiac magnetic resonance. The HCM population (male 75 %; age 47 ± 16 years; NYHA class I or II 95 %; left ventricular ejection fraction 61 ± 3 %; resting left ventricular outflow tract gradient ≥30 mmHg 22 %; late gadolinium enhancement presence 58 %) showed slightly reduced mean peak oxygen uptake values (pVO2 75 ± 15 %, 23.2 ± 6.7 ml/kg/min) with a significant reduction of the achieved percentage of peak heart rate reserve (%pHRR 65 ± 20 %). Adopting a pVO2 <80 % cut-off value, 59 % of HCM patients showed a reduced exercise capacity. Age, male gender, left atrial size, chronotropic and systolic blood pressure response, ventilatory efficiency, late gadolinium enhancement presence and β-blocker therapy were independently associated with pVO2 (R 2-adjusted index 0.738). A %pHRR cut-off value of 74 % appeared to most accurately predict an impaired exercise capacity (area under curve 0.90). A great prevalence of reduced exercise capacity is present in NYHA class I–II HCM patients. Notwithstanding its multifactorial genesis, few parameters might be adopted in identifying this feature. In this context, %pHRR value might represent a reliable and easy-to-obtain tool for the clinical evaluation of HCM patients.
Similar content being viewed by others
References
Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med 316:844–852
Elliott P, McKenna WJ (2004) Hypertrophic cardiomyopathy. Lancet 2004(5):1881–1891
Olivotto I, Cecchi F, Casey SA et al (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524
Harris KM, Spirito P, Maron MS et al (2006) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114:216–225
Autore C, Bernabò P, Barillà CS, Bruzzi P, Spirito P (2005) The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45:1076–1080
Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482
Payá E, Marín F, González J et al (2008) Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail 14:414–419
Briguori C, Betocchi S, Romano M et al (1999) Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol 84:309–315
Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP (1995) Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume, heart rate, and diastolic filling characteristics. Circulation 92:2886–2894
Nistri S, Olivotto I, Betocchi S et al (2006) Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 98:960–965
Matsumura Y, Elliott P, Virdee, Sorajja P, Doi Y, McKenna WJ (2002) Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 87:247–251
Magrì D, Palermo P, Cauti FM et al (2012) Chronotropic incompetence and functional capacity in chronic heart failure: no role of beta-blockers and beta-blocker dose. Cardiovasc Ther 30:100–108
Sharma S, Elliott P, Whyte G et al (2000) Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol 86:162–168
Efthimiadis GK, Giannakoulas G, Parcharidou DG et al (2011) Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy. Int J Cardiol 153:179–184
Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 15:1778–1785
Lang RM, Bierig M, Devereux RB et al (2005) Recommendation for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standard Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Society of Echocardiograph, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463
Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendation for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193
Joshi S, Patel UK, Yao SS et al (2011) Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity. J Am Soc Echocardiogr 24:75–82
Agostoni P, Bianchi M, Moraschi A et al (2005) Work-rate affects cardiopulmonary exercise test results in heart failure. Eur J Heart Fail 7:498–504
Katritsis D, Camm AJ (1993) Chronotropic incompetence: a proposal for definition and diagnosis. Br Heart J 70:400–402
Wilkoff BL, Miller RE (1992) Exercise testing for chronotropic assessment. Cardiol Clin 10:705–717
Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ (2005) Principles of exercise testing and interpretation, 4th edn. Lippincott Williams & Wilkins, Baltimore, pp 10–65
Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L (2006) Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention. Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendation for performance and interpretation. I. Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil 13:150–164
Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215–223
Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374
Metra M, Zacà V, Parati G, Heart Failure Study Group of the Italian Society of Cardiology et al (2011) Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 12:76–84
Magrì D, Volpe M (2009) Cardiopulmonary exercise testing in heart failure: from ugly duckling to swan. Intern Emerg Med 4:263–264
Bonow RO (1992) Determinants of exercise capacity in hypertrophic cardiomyopathy. J Am Coll Cardiol 19:513–515
Dumont CA, Monserrat L, Peteiro J et al (2007) Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy. Am J Cardiol 99:1454–1457
Sachdev V, Shizukuda Y, Brenneman CL et al (2005) Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J 149:730–736
Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ (2012) Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 33:904–912
Guazzi M, Myers J, Arena R (2005) Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 46:1883–1890
Arena R, Owens DS, Arevalo J et al (2008) Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy. Med Sci Sports Exerc 40:799–805
Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Arena R (2010) Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction. J Cardiopulm Rehabil Prev 30:165–172
Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51–58
Motoyasu M, Kurita T, Onishi K et al (2008) Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J 72:378–383
Oka K, Tsujino T, Nakao S et al (2008) Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy. J Cardiol 52:146–153
Brubaker PH, Kitzman DW (2011) Chronotropic incompetence: causes, consequences, and management. Circulation 123:1010–1020
Colucci WS, Ribeiro JP, Rocco MB et al (1989) Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization. Circulation 80:314–323
Phan TT, Shivu GN, Abozguia K et al (2010) Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail 3:29–34
Gilligan DM, Chan WL, Sbarouni E, Nihoyannopoulos P, Oakley CM (1993) Autonomic function in hypertrophic cardiomyopathy. Br Heart J 69:525–529
Fananapazir L, Tracy CM, Leon MB et al (1989) Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 80:1259–1268
Nistri S, Olivotto I, Maron MS et al (2010) Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. Am J Cardiol 106:1301–1306
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magrì, D., Agostoni, P., Cauti, F.M. et al. Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study. Intern Emerg Med 9, 293–302 (2014). https://doi.org/10.1007/s11739-012-0866-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-012-0866-x